55 related articles for article (PubMed ID: 38615082)
1. Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer.
Li X; Guan W; Liu H; Yuan J; Wang F; Guan B; Chen J; Lu Q; Xu G; Zhang L
Apoptosis; 2024 Apr; ():. PubMed ID: 38615082
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.
Chen H; Liu J; Wang H; Cheng Q; Zhou C; Chen X; Ye F
J Cancer; 2019; 10(6):1580-1592. PubMed ID: 31031868
[No Abstract] [Full Text] [Related]
4. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
5. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome.
Mills PB; Camuzeaux SS; Footitt EJ; Mills KA; Gissen P; Fisher L; Das KB; Varadkar SM; Zuberi S; McWilliam R; Stödberg T; Plecko B; Baumgartner MR; Maier O; Calvert S; Riney K; Wolf NI; Livingston JH; Bala P; Morel CF; Feillet F; Raimondi F; Del Giudice E; Chong WK; Pitt M; Clayton PT
Brain; 2014 May; 137(Pt 5):1350-60. PubMed ID: 24645144
[TBL] [Abstract][Full Text] [Related]
6. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract][Full Text] [Related]
7. Clinical and translational advances in ovarian cancer therapy.
Konstantinopoulos PA; Matulonis UA
Nat Cancer; 2023 Sep; 4(9):1239-1257. PubMed ID: 37653142
[TBL] [Abstract][Full Text] [Related]
8. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
González-Martín A; Harter P; Leary A; Lorusso D; Miller RE; Pothuri B; Ray-Coquard I; Tan DSP; Bellet E; Oaknin A; Ledermann JA;
Ann Oncol; 2023 Oct; 34(10):833-848. PubMed ID: 37597580
[No Abstract] [Full Text] [Related]
9. Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines.
Chen JL; Wu X; Yin D; Jia XH; Chen X; Gu ZY; Zhu XM
Pharmacol Ther; 2023 Sep; 249():108485. PubMed ID: 37406740
[TBL] [Abstract][Full Text] [Related]
10. Autophagy and autophagy-related pathways in cancer.
Debnath J; Gammoh N; Ryan KM
Nat Rev Mol Cell Biol; 2023 Aug; 24(8):560-575. PubMed ID: 36864290
[TBL] [Abstract][Full Text] [Related]
11. The multifaced role and therapeutic regulation of autophagy in ovarian cancer.
Nokhostin F; Azadehrah M; Azadehrah M
Clin Transl Oncol; 2023 May; 25(5):1207-1217. PubMed ID: 36534371
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cancer cell death induction by paclitaxel: an updated review.
Zhao S; Tang Y; Wang R; Najafi M
Apoptosis; 2022 Oct; 27(9-10):647-667. PubMed ID: 35849264
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer.
Zhang L; Li X; Zhang J; Xu G
Front Cell Dev Biol; 2021; 9():763674. PubMed ID: 35127701
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
